First-in-human Study of 7MW4911 in GI Cancer
First-in-human Study of 7MW4911 in GI Cancer
Recruiting · NCT07216560 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-human Study of 7MW4911 in GI Cancer | GI Cancers | Recruiting | Phase 1 / Phase 2 | 2026-08-21 | NCT07216560 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mabwell (Shanghai) Bioscience Co., Ltd. | 23 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Hematology Oncology Associates of the Treasure Coast | Port Saint Lucie | United States | 8 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 60 |
| START | Long Island City | United States | 1 |
| START Moutain Region | West Valley City | United States | 2 |